|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan CS, Gilligan D and Pacey S: Treatment
approaches for EGFR-inhibitor-resistant patients with
non-small-cell lung cancer. Lancet Oncol. 16:e447–e459. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Semenova EA, Nagel R and Berns A: Origins,
genetic landscape, and emerging therapies of small cell lung
cancer. Genes Dev. 29:1447–1462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Muller PA and Vousden KH: p53 mutations in
cancer. Nat Cell Biol. 15:2–8. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bieging KT, Mello SS and Attardi LD:
Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev
Cancer. 14:359–370. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chaudhary R and Lal A: Long noncoding RNAs
in the p53 network. Wiley Interdiscip Rev RNA. 8:32017. View Article : Google Scholar
|
|
11
|
Pasic I, Shlien A, Durbin AD, Stavropoulos
DJ, Baskin B, Ray PN, Novokmet A and Malkin D: Recurrent focal
copy-number changes and loss of heterozygosity implicate two
noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31
in osteosarcoma. Cancer Res. 70:160–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: LncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rahman M, Jackson LK, Johnson WE, Li DY,
Bild AH and Piccolo SR: Alternative preprocessing of RNA-Sequencing
data in The Cancer Genome Atlas leads to improved analysis results.
Bioinformatics. 31:3666–3672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J, Lin J, Liu T, Chen T, Pan S, Huang
W and Li S: Analysis of lncRNA expression profiles in non-small
cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer.
85:110–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu G, Chen J, Pan Q, Huang K, Pan J, Zhang
W, Chen J, Yu F, Zhou T and Wang Y: Long noncoding RNA expression
profiles of lung adenocarcinoma ascertained by microarray analysis.
PLoS One. 9:e1040442014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Chen W, Chen J, Pan Q and Pan J:
LncRNA expression profiles of EGFR exon 19 deletions in lung
adenocarcinoma ascertained by using microarray analysis. Med Oncol.
31:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao L, Mai A, Li X, Lai Y, Zheng J, Yang
Q, Wu J, Nan A, Ye S and Jiang Y: LncRNA-DQ786227-mediated cell
malignant transformation induced by benzo(a)pyrene. Toxicol Lett.
223:205–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Q, Zhang S, Liu H, Wu J, Xu E, Peng B
and Jiang Y: Oncogenic role of long noncoding RNA AF118081 in
anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed
16HBE cells. Toxicol Lett. 229:430–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thai P, Statt S, Chen CH, Liang E,
Campbell C and Wu R: Characterization of a novel long noncoding
RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer
cell lines. Am J Respir Cell Mol Biol. 49:204–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaplan R, Luettich K, Heguy A, Hackett NR,
Harvey BG and Crystal RG: Monoallelic up-regulation of the
imprinted H19 gene in airway epithelium of phenotypically normal
cigarette smokers. Cancer Res. 63:1475–1482. 2003.PubMed/NCBI
|
|
25
|
Weber DG, Johnen G, Casjens S, Bryk O,
Pesch B, Jöckel KH, Kollmeier J and Brüning T: Evaluation of long
noncoding RNA MALAT1 as a candidate blood-based biomarker for the
diagnosis of non-small cell lung cancer. BMC Res Notes. 6:5182013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C,
Zhou XY and Du X: Low expression of LOC285194 is associated with
poor prognosis in colorectal cancer. J Transl Med. 11:1222013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ding YC, Yu W, Ma C, Wang Q, Huang CS and
Huang T: Expression of long non-coding RNA LOC285194 and its
prognostic significance in human pancreatic ductal adenocarcinoma.
Int J Clin Exp Pathol. 7:8065–8070. 2014.PubMed/NCBI
|
|
28
|
Collisson EA, Campbell JD, Brooks AN,
Berger AH, Lee W, Chmielecki J, Beer DG, Cope L, Creighton CJ,
Danilova L, et al: ; Cancer Genome Atlas Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han L, Zhang EB, Yin DD, Kong R, Xu TP,
Chen WM, Xia R, Shu YQ and De W: Low expression of long noncoding
RNA PANDAR predicts a poor prognosis of non-small cell lung cancer
and affects cell apoptosis by regulating Bcl-2. Cell Death Dis.
6:e16652015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhai N, Xia Y, Yin R, Liu J and Gao F: A
negative regulation loop of long noncoding RNA HOTAIR and p53 in
non-small-cell lung cancer. OncoTargets Ther. 9:5713–5720. 2016.
View Article : Google Scholar
|
|
32
|
Shi X, Chen Y, Chen AM, Le X, Huang K,
Chen J, Wen S, Zeng H, Chen C and Li J: LncRNA TUSC7 affects
malignant tumor prognosis by regulating protein ubiquitination: A
genome-wide analysis from 10,237 pan-cancer patients. Transl Cancer
Res. 6:834–842. 2017. View Article : Google Scholar
|
|
33
|
Zatsepin TS, Kotelevtsev YV and
Koteliansky V: Lipid nanoparticles for targeted siRNA delivery -
going from bench to bedside. Int J Nanomedicine. 11:3077–3086.
2016. View Article : Google Scholar : PubMed/NCBI
|
